Navigation Links
US Oncology Launches New Flexible Options for Community Oncologists to Join the United Network of US Oncology
Date:5/3/2010

THE WOODLANDS, Texas, May 3 /PRNewswire/ -- US Oncology, Inc., the nation's leading integrated oncology company, today launched new flexible offerings that can be customized to the needs and characteristics of individual community-based oncology practices. Through these expanded offerings, physicians can join more than a thousand oncologists in the United Network of US Oncology to work together to realign reimbursement based on measurable quality care, advance cancer care through clinical research, enhance the patient experience and improve practice productivity.

"We now offer new flexible options for physicians to join the United Network of US Oncology so that more oncologists can participate in programs that have proven value in advancing cancer care and improving practice performance," said Bruce Broussard, Chairman and CEO of US Oncology.

Independent oncology practices can now join the United Network of US Oncology either through a Comprehensive Strategic Alliance relationship or through a NEW more flexible offering called Targeted Physician Services that tailors solutions to meet the individual needs of independent practices. Benefits of joining the United Network of US Oncology include access to:

  • Physician governance and collaboration via nationwide virtual tumor boards, innovative technology, disease-specific committees and face-to-face networking meetings
  • Payer quality services which enable pay for performance and the ability to report on the quality of care
  • Ongoing education and shared best practices
  • Level I Pathways – finely tuned evidence-based clinical guidelines developed by physician-led teams of oncology experts using the gold standard of science – randomized double-blind trials published in peer-reviewed journals
  • Safe and effective drug supplies, protected through e-Pedigree technology
  • Clinical research opportunities from Phase I through Phase IV
  • Oncology-specific electronic health record (EHR) system
  • And other value added services available only through the United Network of US Oncology

Practices with a Targeted Physician Services relationship can join the United Network of US Oncology and remain independent, but have the power and strength of a nationwide network behind them.

US Oncology has a long history of uniting physicians to create innovative solutions for oncology care. The new flexible options allow more physicians to participate and apply these resources to create a better future for cancer care in America. For a full list of United Network of US Oncology members, and to find an affiliated practice or physician, please visit the site map at www.usoncology.com.

About US Oncology

US Oncology, Inc. is the nation's leading integrated oncology company. By uniting the largest community-based cancer treatment and research network in America, US Oncology expands patient access to high-quality care and advances the science of cancer care. Headquartered in The Woodlands, Texas, US Oncology is affiliated with more than 1,300 community-based oncologists, and works with patients, hospitals, payers, and the medical industry across all phases of the cancer research and delivery continuum. Through the use of innovative technology, clinical research, evidence-based medicine and shared best practices, US Oncology improves patient outcomes and offers a better patient experience.

US Oncology unites the nation's largest network of community-based oncology physicians through the United Network of US Oncology. These like-minded physicians are united around a common vision of expanding patient access to high-quality cancer care in communities throughout the nation. Leveraging healthcare information technology, shared best practices, refined evidence-based medicine guidelines, and quality measurements, physician members of the United Network of US Oncology are committed to advancing the quality, safety, and science of cancer care to improve patient outcomes. Members may tailor their business relationship from a suite of solutions ranging from customized targeted physician services to a long-term strategic alliance of comprehensive management solutions. For more information, visit www.usoncology.com.


'/>"/>
SOURCE US Oncology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
2. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
3. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
4. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
6. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
7. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
8. Pharsight Uses FDA Disease Model to Support Oncology Drug Development
9. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
10. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
11. Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
(Date:12/8/2016)... A Small Business Innovative Research (SBIR) grant ... (NIH) to Phoenix -based NeuroEM Therapeutics, ... grant will seek to determine an optimal set of ... waves to treat Alzheimer,s Disease. The grant will also ... treat other neurologic disorders such as Parkinson,s Disease and ...
(Date:12/8/2016)... New York , December 8, 2016 ... global Diabetes Injection Pens Market is expected to ... compared to US$4.9 bn in 2015. Between the forecast years ... rise at a CAGR of 7.9%. The leading players operating ... A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and ...
Breaking Medicine Technology:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused ... in efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, ... is honored to team up with Upstage Lung Cancer in order to make major ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
(Date:12/8/2016)... ... , ... STAT courier is pleased to announce that due to customer demand, ... expanding their presence in Dallas. One of the most exciting parts for STAT is ... the Dallas and Forth Worth market. STAT takes pride in treating their employees with ...
(Date:12/8/2016)... ... 08, 2016 , ... Vida Health, the digital health platform that ... Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning investor ... more consumers who are managing chronic conditions or simply want to improve ...
Breaking Medicine News(10 mins):